Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $33.3B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Cara Therapeutics USD 2K 3K Mar/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
Cronos Group USD 382.89M 286.14M Sep/2025
RedHill Biopharma USD 33.3B 20.4B Jun/2025